Kaplan–Meier survival plots demonstrated increased survival in mice treated with elraglusib alone (50%) which was higher than that with anti-PD-1 treatment alone (30%) when compared to 0% of mice non-treated mice after 18 days post-tumour cell injection. This evidence concerns the gene PDCD1 and neoplasm.